Literature DB >> 12062885

A volumetric MRI study of the entorhinal cortex in first episode neuroleptic-naive schizophrenia.

Christian C Joyal1, Mikko P Laakso, Jari Tiihonen, Erkka Syvälahti, Harry Vilkman, Aki Laakso, Birgitta Alakare, Viljo Räkköläinen, Raimo K R Salokangas, Jarmo Hietala.   

Abstract

BACKGROUND: Imaging studies have frequently reported volume loss of limbic structures in schizophrenia, yet there appears to be no quantitative data on entorhinal cortex volumes in patients with neuroleptic naive first-episode schizophrenia.
METHODS: The volume of the entorhinal cortices of 22 control subjects and 18 patients with neuroleptic-naïve first-episode schizophrenia were measured from magnetic resonance images (MRI) scans using recently designed anatomic criteria for MRI anatomy of the entorhinal cortex.
RESULTS: Smaller entorhinal volumes were found bilaterally in the schizophrenic patients. This volume loss did not correlate with items on the Positive and Negative Syndrome Scale.
CONCLUSIONS: These data suggest early involvement of the entorhinal cortex in schizophrenia.

Entities:  

Mesh:

Year:  2002        PMID: 12062885     DOI: 10.1016/s0006-3223(01)01368-3

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  27 in total

Review 1.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

Review 2.  [Changes in brain structure caused by neuroleptic medication].

Authors:  H Scherk; P Falkai
Journal:  Nervenarzt       Date:  2004-11       Impact factor: 1.214

3.  Modulation of GABAergic transmission by muscarinic receptors in the entorhinal cortex of juvenile rats.

Authors:  Zhaoyang Xiao; Pan-Yue Deng; Chuanxiu Yang; Saobo Lei
Journal:  J Neurophysiol       Date:  2009-06-03       Impact factor: 2.714

4.  Psychopathological correlates of the entorhinal cortical shape in schizophrenia.

Authors:  C Christoph Schultz; Kathrin Koch; Gerd Wagner; Martin Roebel; Claudia Schachtzabel; Igor Nenadic; Carsten Albrecht; Jürgen R Reichenbach; Heinrich Sauer; Ralf G M Schlösser
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11-07       Impact factor: 5.270

5.  Thalamic-insular dysconnectivity in schizophrenia: evidence from structural equation modeling.

Authors:  Corrado Corradi-Dell'Acqua; Luisa Tomelleri; Marcella Bellani; Gianluca Rambaldelli; Roberto Cerini; Roberto Pozzi-Mucelli; Matteo Balestrieri; Michele Tansella; Paolo Brambilla
Journal:  Hum Brain Mapp       Date:  2011-04-11       Impact factor: 5.038

6.  Histamine facilitates GABAergic transmission in the rat entorhinal cortex: Roles of H1 and H2 receptors, Na+ -permeable cation channels, and inward rectifier K+ channels.

Authors:  Nicholas I Cilz; Saobo Lei
Journal:  Hippocampus       Date:  2017-02-28       Impact factor: 3.899

7.  Activation of group II metabotropic glutamate receptors inhibits glutamatergic transmission in the rat entorhinal cortex via reduction of glutamate release probability.

Authors:  Shouping Wang; Xiaotong Chen; Lalitha Kurada; Zitong Huang; Saobo Lei
Journal:  Cereb Cortex       Date:  2011-06-15       Impact factor: 5.357

8.  Serotonergic modulation of Neural activities in the entorhinal cortex.

Authors:  Saobo Lei
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26

9.  Neuropathological and Reelin deficiencies in the hippocampal formation of rats exposed to MAM; differences and similarities with schizophrenia.

Authors:  Julien Matricon; Alfredo Bellon; Helge Frieling; Oussama Kebir; Gwenaëlle Le Pen; Frédéric Beuvon; Catherine Daumas-Duport; Thérèse M Jay; Marie-Odile Krebs
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

10.  Serotonin increases GABA release in rat entorhinal cortex by inhibiting interneuron TASK-3 K+ channels.

Authors:  Pan-Yue Deng; Saobo Lei
Journal:  Mol Cell Neurosci       Date:  2008-07-18       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.